Aderis Acquired by Schwarz Pharma
<UNKNOWN> · 1 known investors
UCB is a global biopharmaceutical company that develops and delivers medicines to treat neurological and autoimmune conditions. The company focuses on improving the lives of patients living with severe diseases through innovative therapeutic solutions.
Biotech